A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
for Focal Segmental Glomerulosclerosis
Sites in Cleveland +21 more locations
Sponsor: Akebia Therapeutics
Sex: All·Age: 18+
Code: NCT07268638·Phase 2·Recruiting·Listed Dec 2025